HORMONE-RECEPTOR-POSITIVE BREAST CANCER
Clinical trials for HORMONE-RECEPTOR-POSITIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new HORMONE-RECEPTOR-POSITIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for HORMONE-RECEPTOR-POSITIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New 'Smart Bomb' drug targets Tough-to-Treat breast cancer
Disease control Not yet recruitingThis study is testing a new drug called ARX788 for people with advanced HER2-low breast cancer that has spread or cannot be removed by surgery. ARX788 is an antibody-drug conjugate, which works like a 'smart bomb'—it attaches to cancer cells and delivers a toxin to kill them. The…
Matched conditions: HORMONE-RECEPTOR-POSITIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Laura Huppert, MD, BA • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Blood test could spare breast cancer patients from harsh chemo
Disease control Not yet recruitingThis study is testing a personalized approach to treat early-stage, hormone-sensitive breast cancer. Before surgery, patients receive a combination of targeted pills instead of standard chemotherapy. Doctors will use a simple blood test to check for cancer DNA. If the blood test …
Matched conditions: HORMONE-RECEPTOR-POSITIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Ancient needles target modern cancer side effect
Symptom relief Not yet recruitingThis study tests whether acupuncture can safely reduce hot flashes in breast cancer patients taking hormone-blocking medications. Sixty women will receive either real or fake acupuncture three times weekly for eight weeks while continuing their standard cancer treatment. Research…
Matched conditions: HORMONE-RECEPTOR-POSITIVE BREAST CANCER
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Symptom relief
Last updated Apr 01, 2026 14:43 UTC
-
Scientists probe Gut's role in cancer drug side effect
Knowledge-focused Not yet recruitingThis study aims to understand why some breast cancer patients experience severe diarrhea while taking the drug abemaciclib. Researchers will compare the gut bacteria of 60 patients who develop diarrhea with those who do not by analyzing stool and blood samples. The goal is to lea…
Matched conditions: HORMONE-RECEPTOR-POSITIVE BREAST CANCER
Sponsor: Hubei Cancer Hospital • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:58 UTC